EAM
SAGE
Eagle Asset Management’s Sage Therapeutics SAGE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-480,181
| Closed | -$67.4M | – | 656 |
|
|
2019
Q3 | $67.4M | Sell |
480,181
-57,469
| -11% | -$8.06M | 0.35% | 108 |
|
|
2019
Q2 | $98.4M | Buy |
537,650
+1,978
| +0.4% | +$362K | 0.5% | 61 |
|
|
2019
Q1 | $85.2M | Sell |
535,672
-111,670
| -17% | -$17.8M | 0.45% | 70 |
|
|
2018
Q4 | $62M | Sell |
647,342
-6,672
| -1% | -$639K | 0.39% | 90 |
|
|
2018
Q3 | $92.4M | Buy |
654,014
+71,032
| +12% | +$10M | 0.45% | 63 |
|
|
2018
Q2 | $91.3M | Sell |
582,982
-32,231
| -5% | -$5.05M | 0.49% | 55 |
|
|
2018
Q1 | $99.1M | Sell |
615,213
-3,815
| -0.6% | -$614K | 0.54% | 44 |
|
|
2017
Q4 | $102M | Sell |
619,028
-8,003
| -1% | -$1.32M | 0.56% | 40 |
|
|
2017
Q3 | $39.7M | Sell |
627,031
-40,165
| -6% | -$2.54M | 0.23% | 150 |
|
|
2017
Q2 | $53.1M | Sell |
667,196
-950
| -0.1% | -$75.7K | 0.32% | 105 |
|
|
2017
Q1 | $47.5M | Sell |
668,146
-3,660
| -0.5% | -$260K | 0.3% | 102 |
|
|
2016
Q4 | $34.3M | Buy |
671,806
+41,312
| +7% | +$2.11M | 0.23% | 139 |
|
|
2016
Q3 | $29M | Sell |
630,494
-243,430
| -28% | -$11.2M | 0.2% | 164 |
|
|
2016
Q2 | $26.3M | Buy |
873,924
+27,319
| +3% | +$823K | 0.18% | 166 |
|
|
2016
Q1 | $27.1M | Sell |
846,605
-17,765
| -2% | -$570K | 0.19% | 168 |
|
|
2015
Q4 | $50.4M | Buy |
864,370
+112,567
| +15% | +$6.56M | 0.34% | 99 |
|
|
2015
Q3 | $31.8M | Sell |
751,803
-6,419
| -0.8% | -$272K | 0.22% | 156 |
|
|
2015
Q2 | $55.4M | Buy |
+758,222
| New | +$55.4M | 0.31% | 117 |
|